The effect of the AMPA/kainate receptor antagonist LY293558 in a rat model of postoperative pain

被引:47
|
作者
Lee, Hae-Jin
Pogatzki-Zahn, Esther M.
Brennan, Timothy J.
机构
[1] Univ Iowa, Dept Anesthesia, Coll Med, Iowa City, IA 52242 USA
[2] Univ Munster, Klin & Poliklin Anesthesiol & Operat Intens Med, D-4400 Munster, Germany
来源
JOURNAL OF PAIN | 2006年 / 7卷 / 10期
关键词
glutamate; incision; nonNMDA; hyperalgesia;
D O I
10.1016/j.jpain.2006.03.010
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Non-N-methyl-D-aspartate (non-NMDA) glutamate receptor antagonists modify multiple pain transmission pathways and are of particular interest in analgesic development because of their capacity to interfere with evoked pain. Evoked pain is a problem for postoperative patients and is characteristic of the plantar incision model for postoperative pain. The purpose of this study was to assess the efficacy of a non-NMDA receptor antagonist LY293558 on mechanical hyperalgesia after plantar incision in the rat. Parenteral, intrathecal, or intraplantar administration of LY293558 was tested against the mechanical hyperalgesia that characterizes the model. Sprague-Dawley rats were assigned to 1 of 3 groups. LY293558 or vehicle was administered intraperitoneally, intrathecally, or intraplantarly. The hind paw withdrawal threshold to punctate stimulation by using von Frey filaments and response frequency to a nonpunctate stimulus directly to the wound were measured. Motor tests after administration of LY293558 were also examined in rats that did not undergo incision. The greatest dose of parenterally administered LY293558 (34 mu mol/kg) decreased the responses to mechanical stimuli after plantar incision. Rotorod performance was decreased at these same times. Intrathecal injection of LY293558 (0.5 and 2.0 nmol) produced inhibition of mechanical sensitivity and produced lower extremity motor side effects. Repeated intrathecal administration produced sustained anesthesia for 24 hours but had no analgesic effect the next day. Local administration did not decrease response after incision. LY293558 was most effective for evoked pain when administered intrathecally. Perspective: Control of evoked pain after surgery is inadequate but is linked to perioperative outcome. These data suggest that non-NMDA receptor antagonists like LY293558 will be most effective for evoked pain in postoperative patients if administered spinally. (c) 2006 by the American Pain Society
引用
收藏
页码:768 / 777
页数:10
相关论文
共 50 条
  • [31] Epidural tezampanel, an AMPA/kainate receptor antagonist, produces postoperative analgesia in rats
    Jin, Hee Cheol
    Keller, Amber J.
    Jung, Jong Kwon
    Subieta, Alberto
    Brennan, Timothy J.
    ANESTHESIA AND ANALGESIA, 2007, 105 (04): : 1152 - 1159
  • [32] PROTECTION FROM HIGH-PRESSURE INDUCED HYPEREXCITABILITY BY THE AMPA KAINATE RECEPTOR ANTAGONISTS GYKI-52466 AND LY-293558
    PEARCE, PC
    MACLEAN, CJ
    SHERGILL, HK
    WARD, EM
    HALSEY, MJ
    TINDLEY, G
    PEARSON, J
    MELDRUM, BS
    NEUROPHARMACOLOGY, 1994, 33 (05) : 605 - 612
  • [33] Influence of the combined treatment of LY 300164 (an AMPA/kainate receptor antagonist) with adenosine receptor agonists on the electroconvulsive threshold in mice
    Borowicz, KK
    Swiader, M
    Wielosz, M
    Czuczwar, SJ
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 (05) : 407 - 412
  • [34] The GluK1 (GluR5) Kainate/α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptor Antagonist LY293558 Reduces Soman-Induced Seizures and Neuropathology
    Figueiredo, Taiza H.
    Qashu, Felicia
    Apland, James P.
    Aroniadou-Anderjaska, Vassiliki
    Souza, Adriana P.
    Braga, Maria F. M.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 336 (02): : 303 - 312
  • [35] Influence of LY 300164, an antagonist of AMPA/kainate receptors, on the anticonvulsant activity of clonazepam
    Borowicz, KK
    Luszczki, J
    Szadkowski, M
    Kleinrok, Z
    Czuczwar, SJ
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 380 (2-3) : 67 - 72
  • [36] KAINATE BINDING TO THE AMPA RECEPTOR IN RAT-BRAIN
    HALL, RA
    KESSLER, M
    LYNCH, G
    NEUROCHEMICAL RESEARCH, 1994, 19 (06) : 777 - 782
  • [37] Effect of hyperglycemia and diabetes on the expression of AMPA and kainate receptor subunits in rat retina
    Santiago, AS
    Neto, AM
    Rosa, S
    Santos, PF
    Cristovao, A
    Ambrósio, AF
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U90 - U90
  • [38] AMPA/kainate receptor antagonist tezampanel is effective in treating acute migraine
    Murphy, M. F.
    Mellberg, S. J.
    Kurtz, N. M.
    Graham, E. A.
    HEADACHE, 2008, 48 : S8 - S8
  • [39] The competitive α-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to delta or kappa opioids
    Kest, B
    McLemore, G
    Kao, B
    Inturrisi, CE
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 283 (03): : 1249 - 1255
  • [40] LY 300164, a novel antagonist of AMPA/kainate receptors, potentiates the anticonvulsive activity of antiepileptic drugs
    Czuczwar, SJ
    Swiader, M
    Kuzniar, H
    Gasior, M
    Kleinrok, Z
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 359 (2-3) : 103 - 109